Tuesday, 02 January 2024 12:17 GMT

Wound Care Market Size & Share Analysis 2025-2033 - Shift Towards Advanced Wound Care Products Spurs Global Market Expansion


(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The "Wound Care Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets's offering.
The Global Wound Care Market size was worth USD 21.44 billion in 2024 and is anticipated to grow at a CAGR of 5.76% from 2025 to 2033 to reach USD 35.48 billion by 2033. The market is boosted by the growing number of chronic wounds, rising geriatric population, rising cases of diabetes and obesity, and improvements in wound care technologies.

Growing Incidence of Chronic Disorders

The global surge in chronic ailments like diabetes, obesity, and cardiovascular disorders is strongly increasing the demand for wound care solutions. Diabetic foot ulcers, pressure sores, and venous leg ulcers are a few of the most prevalent chronic wounds that necessitate extended treatment and advanced therapies.

With the aging population worldwide, more patients with comorbidities are on the rise, thus enhancing the prevalence of chronic wounds, which in turn increases the demand for wound care products and treatments such as NPWT, bioactive dressings, and moisture-retentive dressings, particularly in inpatient and outpatient clinics. For example, as per the International Diabetes Federation Atlas report, there is expected to be a huge surge in the number of diabetics, from 463 million in 2019 to 578 million in 2030 and an estimated 700 million by 2045.

Technological Developments in Wound Care Products

Sustained technological advancements in wound care technology, including advanced dressings with real-time feedback, bioengineered skin substitutes, and novel hydrogels, are revolutionizing wound management. These technologies provide better healing times, lower infection risk, and better patient comfort. For instance, antimicrobial dressings containing silver or iodine assist in quicker infection control, while tissue regeneration is stimulated by growth factor-infused dressings.

The integration of digital health solutions and telemedicine in the assessment and treatment of wounds is also becoming popular, making sophisticated wound care more effective and accessible for all healthcare settings globally. In January 2023, Convatec Group (UK) introduced ConvaFoam, which is applied on a range of wound types in any phase of the wound journey, positioning it as the easy dressing option for skin protection and wound management.

Increased Surgical Procedures and Traumatic Injuries

Increased surgical procedures across the world, fueled by emergency and elective procedures, are a key growth driver of the wound care market. Wounds following surgery must be managed cautiously to avoid infections and complications, thus the need for advanced dressings and closure systems for wounds. Road traffic accidents, workplace accidents, and sports injuries are also among the rising causes of acute wounds. With hospitals aiming for improved results and shorter hospital stays, the use of sophisticated wound care products for inpatient and outpatient recuperation has significantly risen in developed and developing nations.

June 2024, Axogen, Inc., a pioneer in surgical solutions for peripheral nerve injuries, has introduced Avive+ Soft Tissue MatrixT, a resorbable, multi-layer amniotic membrane allograft. Formulated as a soft tissue barrier, Avive+ offers temporary protection and separation of tissues during the critical healing phase of nerves. It is processed and distributed according to FDA regulations for Human Cellular and Tissue-based Products under Part 1271 and U.S. State regulation as a 361 human tissue product.

Excessive Cost of Sophisticated Wound Care Products

One of the major impediments in the global wound care market is the excessive cost involved in sophisticated dressings, skin substitutes, and treatments such as NPWT. Although effective, these products prove to be cost-prohibitive for patients from low-income economies or those with no health coverage. The economic burden is especially daunting within home care environments in which patients require extended care. This cost difference restricts the implementation of advanced wound care, particularly in rural or underdeveloped areas where basic or traditional wound management is commonly practiced.

Limited Awareness and Trained Personnel in Emerging Markets

Healthcare professionals and patients in most developing areas are not aware of the availability and benefits of sophisticated wound care products. Moreover, the lack of skilled wound care professionals presents an even bigger challenge in providing the best treatment. Inadequate infrastructure, late diagnosis, and poor follow-up care add to the problem. These constraints tend to extend the process of healing, increase the rate of infection, and elevate the cost of healthcare, thus affecting the growth of the market overall in such countries.

Key Attributes

Report Attribute Details
No. of Pages 200
Forecast Period 2024-2033
Estimated Market Value (USD) in 2024 $21.44 Billion
Forecasted Market Value (USD) by 2033 $35.48 Billion
Compound Annual Growth Rate 5.7%
Regions Covered Global

Key Topics Covered
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Driver
4.2 Challenges
5. Global Wound Care Market
6. Market Share Analysis
6.1 Wound Type
6.2 Products
6.3 Application
6.4 End User
6.5 Countries
7. Wound Type
7.1 Advanced wound Dressings
7.2 Traditional Wound Care Products
7.3 Negative Pressure Wound Therapy
7.4 Bioactive
7.5 Others
8. Products
8.1 Growth Factors
8.2 Foam
8.3 Antimicrobial
8.4 Alginate
8.5 Traditional Adhesive
8.6 Hydrocolloid
8.7 Hydrogel
8.8 Traditional Gauze
8.9 Film
8.10 Traditional Non-Adherent
8.11 Others
9. Application
9.1 Chronic Wounds
9.2 Acute Wounds
10. End User
10.1 Home Care Settings
10.2 Long-term care Facilities
10.3 Hospital & Clinics
11. Countries
11.1 North America
11.1.1 United States
11.1.2 Canada
11.2 Europe
11.2.1 France
11.2.2 Germany
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Belgium
11.2.7 Netherlands
11.2.8 Turkey
11.3 Asia-Pacific
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 Australia
11.3.5 South Korea
11.3.6 Thailand
11.3.7 Malaysia
11.3.8 Indonesia
11.3.9 New Zealand
11.4 Latin America
11.4.1 Brazil
11.4.2 Mexico
11.4.3 Argentina
11.5 Middle East & Africa
11.5.1 South Africa
11.5.2 Saudi Arabia
11.5.3 United Arab Emirates
12. Porter's Five Forces
12.1 Bargaining Power of Buyers
12.2 Bargaining Power of Suppliers
12.3 Degree of Rivalry
12.4 Threat of New Entrants
12.5 Threat of Substitutes
13. SWOT Analysis
13.1 Strength
13.2 Weakness
13.3 Opportunity
13.4 Threat
14. Company Analysis
14.1 Molnlycke Healthcare
14.1.1 Overviews
14.1.2 Key Persons
14.1.3 Recent Developments
14.1.4 Product Portfolio
14.1.5 Revenue
14.2 Smith & Nephew
14.3 Ethicon Inc (Johnson & Johnson)
14.4 Coloplast Corp
14.5 ConvaTec Group PLC
14.6 Derma Sciences Inc. (Integra LifeSciences)
For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

  • Wound Care Market
CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN30102025004107003653ID1110271873



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search